Miguel Hueda-Zavaleta

Dr. Miguel Hueda-Zavaleta

Faculty of health sciences, Universidad Privada de Tacna, Perú
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
Miguel Hueda-ZavaletaMiguel Hueda-Zavaleta
Miguel Hueda-Zavaleta
Cesar Augusto Copaja CorzoCesar Augusto Copaja Corzo
Cesar Augusto Copaja Corzo
FBFabrizzio Bardales-Silva
Fabrizzio Bardales-Silva
RPRodrigo Jesús Flores Palacios
Rodrigo Jesús Flores Palacios
LBLuis Barreto-Rocchetti
Luis Barreto-Rocchetti
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
Objetivo: Describir las características demográficas, clínicas, laboratoriales y de tratamiento de pacientes hospitalizados por la COVID-19 y determinar los factores de riesgo de mortalidad hospitalaria. Materiales y métodos: Estudio de cohorte retrospectivo de pacientes adultos hospitalizados por la COVID-19. Se extrajeron datos demográficos, clínicos, laboratoriales y de tratamiento de las historias clínicas de pacientes que ingresaron al Hospital III Daniel Alcides Carrión de Tacna. Para el análisis de supervivencia se empleó el modelo de riesgos proporcionales de Cox y se calcularon los cocientes de riesgo instantáneos (HR) crudos y ajustados con sus respectivos intervalos de confianza al 95% (IC 95%). Resultados: Se evaluó a 351 pacientes, el 74,1% eran hombres; las comorbilidades más comunes fueron obesidad (31,6%), hipertensión (27,1%) y diabetes mellitus (24,5%). La mediana de tiempo de hospitalización fue 8 días (RIC: 4-15). El 32,9% falleció durante el seguimiento. El análisis multivariado mostró un aumento del riesgo de morir asociado a la edad ≥65 años, HR = 3,55 (IC 95%: 1,70-7,40); al incremento de lactato deshidrogenasa 720 U/L, HR = 2,08 (IC 95%: 1,34-3,22); y a la saturación de oxígeno por debajo del 90%, principalmente cuando fue menor al 80%, HR = 4,07 (IC 95%: 2,10-7,88). Además, el uso de colchicina en el tratamiento tuvo un efecto protector, HR = 0,46 (IC 95%: 0,23-0,91). Conclusiones: Los factores de riesgo de muerte por la COVID-19 incluyeron ser mayor de 65 años, tener saturación de oxígeno menor de 90% y elevación del lactato deshidrogenasa 720 U/L; el tratamiento con colchicina podría mejorar el pronóstico de los pacientes.

2 July 2025 in Travel Medicine and Infectious Disease
Verified
Journal Article
Open access
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales
AAAbdulaziz Alhazmi
Abdulaziz Alhazmi
AKABRAHAM KATIME
ABRAHAM KATIME
AHAhneez Abdul Hameed
Ahneez Abdul Hameed
AMAlejandra Morales
Alejandra Morales
ESEsgitm Slamvi
Esgitm Slamvi

1 November 2023 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
FKFiorella Krapp
Fiorella Krapp
CGCoralith García
Coralith García
NHNoemi Hinostroza
Noemi Hinostroza
LALizeth Astocondor
Lizeth Astocondor
CRClaudia R. Rondon
Claudia R. Rondon
JJJan Jacobs
Jan Jacobs
: Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.

22 September 2022 in Medicina
Verified
Journal Article
Open access
PDF file
Cesar Augusto Copaja CorzoCesar Augusto Copaja Corzo
Cesar Augusto Copaja Corzo
BCBrayan Raul Miranda Chavez
Brayan Raul Miranda Chavez
DJDariela Belén Vizcarra Jiménez
Dariela Belén Vizcarra Jiménez
Miguel Hueda-ZavaletaMiguel Hueda-Zavaleta
Miguel Hueda-Zavaleta
MRMarco Rivarola-Hidalgo
Marco Rivarola-Hidalgo
ATAlvaro Taype-Rondan
Alvaro Taype-Rondan
Background and objectives: Sleep disorders are a common public health problem among college students. The objective of this study was to evaluate sleep quality and its associated factors in medical students during the COVID-19 pandemic. Materials and Methods: Cross-sectional analytical study—we conducted a secondary analysis of the survey “Nomophobia in medical students in Peru” database between 2020 and 2021. Sleep disturbances were assessed using the Pittsburgh Sleep Quality Index (PSQI). To evaluate associated factors, crude and adjusted prevalence ratios (aPR) and their 95% confidence intervals (95% CI) were calculated. Results: We analyzed data from 3139 participants from 18 cities in Peru (61.1% were women, median age: 22 years). 43.4% had a quality of sleep that could require medical attention; the PSQI dimension with the highest score was daytime dysfunction. The poor sleep quality was associated with symptoms of anxiety (aPR: 1.48; 95% CI: 1.27–1.72), depression (aPR: 2.03; 1.72–2.39), or nomophobia (aPR: 1.28; 1.09–1.51). Conclusions: Sleep disorders were a common problem among Peruvian medical students and were associated with anxiety, depression, or nomophobia symptoms.

25 June 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Cesar Augusto Copaja CorzoCesar Augusto Copaja Corzo
Cesar Augusto Copaja Corzo
JFJavier A. Flores-Cohaila
Javier A. Flores-Cohaila
GTGustavo Tapia-Sequeiros
Gustavo Tapia-Sequeiros
JVJennifer Vilchez-Cornejo
Jennifer Vilchez-Cornejo
Miguel Hueda-ZavaletaMiguel Hueda-Zavaleta
Miguel Hueda-Zavaleta
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
Background: Dengue has emerged as an unprecedented epidemic in Peru, and it is anticipated that this issue will escalate further owing to climate change. This study aimed to determine the risk factors associated with death from dengue in patients treated at Hospital II in Pucallpa, Peru. Methodology: This retrospective cohort study collected information from the medical records of patients with a diagnosis of dengue treated at Hospital II Pucallpa-Peru between January 2019 and March 2023. The primary outcome was death, and the secondary outcome was death, development of severe dengue, or Intensive Care Unit (ICU) admission. Cox regression models were used to determine risk factors. Findings: The clinical records of 152 patients were evaluated, with a median age of 27.5 years (interquartile range, 11–45). Among all patients, 29 (19.1%) developed severe dengue, 31 (20.4%) were admitted to the ICU, and 13 (8.6%) died during follow-up. In the survival analysis, bilirubin >1.2 mg/dL was associated with a higher risk of death aHR: 11.38 (95% CI: 1.2 106.8). Additionally, factors associated with poor prognosis included having 1 to 3 comorbidities aRR: 1.92 (1.2 to 3.2), AST ≥251 U/L aRR: 6.79 (2.2 to 21.4), history of previous dengue aRR: 1.84 (1.0 to 3.3), and fibrinogen ≥400 mg/dL aRR: 2.23 (1.2 to 4.1). Significance: Elevated bilirubin was associated with death from dengue, whereas an increase in comorbidities and a history of previous dengue were related to a poor prognosis of the disease. Early identification of severe dengue would be more feasible with improved access to laboratory testing, particularly in tropical areas with a high dengue incidence.

Verified
Journal Article
Open access
PDF file
DJDariela Belén Vizcarra Jiménez
Dariela Belén Vizcarra Jiménez
CBClaudia Fiorella Barletta-Carrillo
Claudia Fiorella Barletta-Carrillo
Miguel Hueda-ZavaletaMiguel Hueda-Zavaleta
Miguel Hueda-Zavaleta
EPEdgar G. Parihuana-Travezaño
Edgar G. Parihuana-Travezaño
MGMaykel Gutierrez-Flores
Maykel Gutierrez-Flores
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
Reducing neonatal mortality is a global challenge. This study’s objective was to determine the predictors of mortality in patients with neonatal sepsis. The study was a retrospective cohort study in a Peruvian hospital from January 2014 to April 2022. Neonates diagnosed with sepsis were included. To find predictors of mortality, we used Cox proportional regression models. We evaluated 288 neonates with sepsis; the median birth weight and hospitalization time were 3270 g and seven days, respectively. During follow-up, 18.4% did not survive, and the most common complications were jaundice (35.42%), respiratory distress syndrome (29.51%), and septic shock (12.5%). The most isolated bacteria were Klebsiella pneumoniae. The risk factors associated with higher mortality were prematurity (aHR = 13.92; 95% CI: 1.71–113.51), platelets <150,000 (aHR = 3.64; 1.22–10.88), creatinine greater than 1.10 (aHR = 3.03; 1.09–8.45), septic shock (aHR = 4.41; 2.23–8.74), and admission to IMV (aHR = 5.61; 1.86–16.88), On the other hand, breastfeeding was associated with a lower risk of death (aHR = 0.25; 0.13–0.48). In conclusion, we report a high incidence of death and identify clinical (prematurity, septic shock, admission to IMV) and laboratory characteristics (elevated creatinine and thrombocytopenia) associated with higher mortality in patients with neonatal sepsis. Breastfeeding was a factor associated with survival in these patients.